Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Kolmar Korea Co. Ltd. manages a portfolio with 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 4 distinct examiners and 3 distinct art units. This distribution indicates a range of patent applications within the life sciences sector, as the company is engaging with 3 distinct art units at the USPTO. The variety of art units suggests that the company's research and development efforts span several different technical sub-fields.
The busiest examiner for the company is HOLT, ANDRIAE M, who is currently handling 1 busiest examiner pending office action. Because each of the 4 pending office actions is assigned to a different examiner, the workload is distributed across 4 distinct examiners. This lack of concentration suggests that the company's prosecution success is subject to the perspectives and timelines of several different examiners and art units. Practitioners must manage multiple distinct prosecution tracks simultaneously to maintain the momentum of the overall portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLT, ANDRIAE M | 1 | 49.3% | +22.9% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.0% |
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
| MAEWALL, SNIGDHA | 1 | 58.8% | +10.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552426 | MULTILAYER EMULSION COSMETIC COMPOSITION | SCOTLAND, REBECCA LYNN | 5d |
| 18931272 | SULFATE-BASED SURFACTANT FREE ORAL CARE COMPOSITION WITH IMPROVED LOW TEMPERATURE STABILITY | HOLT, ANDRIAE M | — |
| 18572618 | ANTIBACTERIAL COMPOSITION | CHEN, CATHERYNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18931272 | SULFATE-BASED SURFACTANT FREE ORAL CARE COMPOSITION WITH IMPROVED LOW TEMPERATURE STABILITY | HOLT, ANDRIAE M | — |
| 18572618 | ANTIBACTERIAL COMPOSITION | CHEN, CATHERYNE | — |
| 17639011 | DISPERSION OF CERIUM OXIDE FOR ENHANCING SKIN BARRIER, SKIN MOISTURIZING, AND/OR BLOCKING FINE DUST, AND COSMETIC COMPOSITION COMPRISING SAME | MAEWALL, SNIGDHA | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 1615 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18931272 | SULFATE-BASED SURFACTANT FREE ORAL CARE COMPOSITION WITH IMPROVED LOW TEMPERATURE STABILITY | HOLT, ANDRIAE M | — | §102§103 | Non-Final OA | — | Pending | Oct 30, 2024 |
| 18572618 | ANTIBACTERIAL COMPOSITION | CHEN, CATHERYNE | 1655 | §101§103§112 | Final Rejection | — | Pending | Dec 20, 2023 |
| 18552426 | MULTILAYER EMULSION COSMETIC COMPOSITION | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Non-Final OA | 5d | Pending | Sep 25, 2023 |
| 17639011 | DISPERSION OF CERIUM OXIDE FOR ENHANCING SKIN BARRIER, SKIN MOISTURIZING, AND/OR BLOCKING FINE DUST, AND COSMETIC COMPOSITION COMPRISING SAME | MAEWALL, SNIGDHA | 1612 | §103 | Final Rejection | — | Pending | Feb 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial